Large-cap Healthcare company Pfizer has moved -4.6% so far today on a volume of 20,496,616, compared to its average of 20,769,225. In contrast, the S&P 500 index moved 0.2%.
If you are considering an investment in PFE, you'll want to know the following:
-
Pfizer's current price is 81.2% above its Graham number of $26.8, which implies that at its current valuation it does not offer a margin of safety
-
Based on its trailing earnings per share of 1.71, Pfizer has a trailing 12 month Price to Earnings (P/E) ratio of 28.4 while the S&P 500 average is 15.97
-
PFE has a forward P/E ratio of 15.4 based on its forward 12 month price to earnings (EPS) of $3.16 per share
-
Its Price to Book (P/B) ratio is 4.3 compared to its sector average of 4.07
-
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
-
Based in New York, the company has 79,000 full time employees and a market cap of $272,564,338,688. Pfizer currently returns an annual dividend yield of 3.0%.